Luis E. Raez

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers”.

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

The Oncologist(2022)10.1093/oncolo/oyac080

N/A

1.7DataRank · unranked

49 citations

Christina S. Baik, Jessica R. Bauman, Jill Gilbert, Marcia S. Brose, Juneko E. Grilley‐Olson +13 more

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.017

N/A

0.975DataRank · unranked

662 citations

Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési +23 more

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3305

N/A

0.725DataRank · unranked

125 citations

Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich +15 more

Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)

Clinical Lung Cancer(2023)10.1016/j.cllc.2022.11.007

N/A

0.701DataRank · unranked

106 citations

Kayla Brice, Katerine Dumais, Alejandro Lopez-Cohen, Delia Wietecha, Paola A. Izquierdo +3 more

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Lung Cancer(2021)10.1016/j.lungcan.2021.08.010

N/A

0.416DataRank · unranked

15 citations

Mohammad Asad, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Ammar Sukari, Yasmine Baca +18 more

Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9544

N/A

0.269DataRank · unranked

5 citations

Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Yasmine Baca, Joanne Xiu +14 more

Co-mutational status and PD-L1 expression in KRAS mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9038

N/A

0.165DataRank · unranked

2 citations

Julia Judd, Joanne Xiu, Asad Ullah, Girindra Ghanshyam Raval, Patrick C. Ma +12 more